The New York Times Features Daniel L. Doctoroff, Target ALS Founder

February 6, 2013

With A.L.S. in Family, Chief at Bloomberg Joins Fight

Read the full New York Times story. 

Tags

Related News

The ALS Global Research Initiative: Pioneering ALS Research Across the Globe

January 27, 2026

Inside a Global Effort to Understand ALS Resilience

January 27, 2026

Placeholder image

Target ALS and Regeneron Partner to Expand Access to a Novel C9orf72 ALS/FTD Mouse Model

January 27, 2026

Placeholder image

Target ALS Grantee NRG Therapeutics Advances NRG5051 into Phase I Clinical Trial

January 26, 2026